BRAF and thyroid cancer: Subsequently, Brauner et al. [79] demonstrated that BRAF(V600E)-mutated thyroid cell lines and tumor specimens demonstrated higher baseline PD-L1 mRNA expression than BRAF-WT thyroid cells and tumor specimens in a murine thyroid cancer model.